Molecular Biotechnology: Principles and Applications - Glick, B., & Pasternak, J. 2002

Regulation of Research in Molecular Biotechnology and Patenting of Biotechnological Inventions
Control and Regulation of Biotechnological Applications

All breakthrough technologies impact societal development in one way or another. Their emergence gives rise to various challenges—economic, social, and ethical—all of which stem from the integration of novel approaches that displace Traditional Methods. Molecular biology is no exception. Moreover, by dealing with living organisms, it touches upon vital, long-established foundations, stirring public debate. Questions arise regarding the legitimacy of new biotechnological approaches and how to ensure their controlled and safe Structure/175.html">Implementation. In Part IV, we will analyze several socially significant aspects of the development and Application of Molecular biotechnology methods, including The regulation of recombinant DNA research, The production of genetically modified foods, the oversight of transgenic Organism release into the environment, the approval and Practical Application of Gene Therapy methods, and the Patenting of Biotechnological Inventions.

The Introduction of revolutionary technologies, including molecular biotechnology, is invariably accompanied by intense public scrutiny. For some, new technologies are the harbingers of imminent catastrophe, undermining the very foundations of society. Such individuals believe that any innovation inherently harbors danger, which can be avoided only by halting all research entirely. Others view new technologies as a cornucopia from which untold blessings will pour upon humanity, and they argue that any obstacles to their development deprive society of invaluable benefits. They consider new technology to be a fragile entity that requires protection to yield its expected fruits. A third group holds a middle-ground perspective. Its representatives believe that nothing fundamentally new exists at all, and that any "new" technology is simply an Evolution of the old. Such people are entirely satisfied with existing regulatory mechanisms that mitigate risk, confident that the benefits of the new technology will inevitably materialize once it gains a firm footing.

Because molecular biotechnology can impact diverse facets of modern society, including agriculture and medicine, it is essential to address all associated ethical, legal, economic, and social issues. As early as 1973, serious concerns were raised regarding the safety of Recombinant DNA technology. Scientists even felt compelled to impose a moratorium on certain lines of research in this field until official safety guidelines for working with recombinant microorganisms could be established. Under these rules, experiments were restricted to strains incapable of proliferating outside the laboratory, and researchers themselves had to be safeguarded against any potential hazards. The regulations were developed in 1974–1975 through open debate and under intense media scrutiny, providing the public with a thorough understanding of both the negative and positive consequences of genetic manipulation in living organisms. Nevertheless, into the late 1970s, doubts persisted regarding the safety of recombinant DNA work. In particular, fears lingered that the release of genetically modified organisms into the environment could lead to their uncontrolled spread within ecosystems. Consequently, additional safeguards were introduced to minimize the already low probability of such events.

A broad debate also unfolded concerning the ethics of conducting genetic experiments on humans. Its goal was to draw a clear line between what is entirely unacceptable and what is ethically permissible. Unfortunately, there are no simple, definitive Answers to all the ethical, legal, and social questions raised by the diverse Applications of molecular biotechnology. Nevertheless, the stakes are exceedingly high, making a thorough analysis of these issues indispensable.